Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, 3311-1 Yakushiji, Shimotsuke, Tochigi, 329-0498, Japan.
Hypertens Res. 2024 Oct;47(10):2711-2717. doi: 10.1038/s41440-024-01860-y. Epub 2024 Aug 29.
Renal denervation (RDN) is a minimally invasive, endovascular catheter-based procedure using radiofrequency, ultrasound, or alcohol-mediated ablation to treat resistant hypertension. As more attention is focused on the renal sympathetic nerve as a cause and treatment target of hypertension, understanding the anatomy of the renal artery may have important implications for determining endovascular treatment strategies as well as for future selection of devices and appropriate candidates for RDN treatment. However, the anatomical structure of the renal artery (RA) is complex, and standardized morphological evaluations of the RA structure are lacking. Computed tomography angiography or magnetic resonance angiography imaging is useful for assessing RA anatomy before conducting RDN. RA echocardiography is an established noninvasive screening method for significant stenosis. Major randomized controlled trials have limited enrollment to patients with preserved renal function, usually defined as an estimated glomerular filtration rate (eGFR) ≥ 45 mL/min/1.73 m. Therefore, the level of renal function at which RDN is indicated has not yet been determined. This mini-review summarizes the characteristics of renal artery anatomy and renal function that constitute indications for renal denervation. (Role of Clinical Trials: K. Kario is an Executive Committee Principal Investigator for the Spyral OFF MED, the Spyral ON MED, the DUO and the REQUIRE; a Coordinating investigator for the TCD-16164 study; a Site Principal Investigator for the HTN-J, the Spyral OFF MED, the Spyral ON MED, the DUO, the REQUIRE and the TCD-16164 study). Evaluation of renal arteries for radiofrequency renal denervation. A Simultaneous quadrantal ablations at four sites in the main renal artery or the equivalent renal artery to the main renal artery. B If there is a renal artery branch with a diameter >3 mm in the middle of the main renal artery, this branch is the distal end of the main renal artery. In this case, four simultaneous and quadrantal ablations can be performed on the equivalent renal arteries. C Four simultaneous and quadrantal ablations can be performed in the branch renal artery. D Sonication should be spaced at least 5 mm (one transducer*) apart. Perform 2 to 3 mm proximal to the arterial bifurcation. Perform 2 to 3 mm distal to the abdominal aortic inlet.
肾动脉去神经术(RDN)是一种微创的血管内导管介入治疗方法,使用射频、超声或酒精介导消融来治疗难治性高血压。随着人们越来越关注肾脏交感神经作为高血压的病因和治疗靶点,了解肾动脉的解剖结构可能对确定血管内治疗策略以及未来选择设备和 RDN 治疗的合适患者具有重要意义。然而,肾动脉(RA)的解剖结构复杂,缺乏标准化的形态学评估。在进行 RDN 之前,计算机断层血管造影或磁共振血管造影成像有助于评估 RA 解剖结构。RA 超声心动图是一种已建立的用于评估显著狭窄的非侵入性筛查方法。主要的随机对照试验仅招募肾功能正常的患者,通常定义为估计肾小球滤过率(eGFR)≥45ml/min/1.73m。因此,尚未确定 RDN 适用的肾功能水平。这篇小型综述总结了构成 RDN 适应证的肾动脉解剖结构和肾功能的特点。(临床试验的作用:K. Kario 是 Spyral OFF MED、Spyral ON MED、DUO 和 REQUIRE 的执行委员会主要研究者;TCD-16164 研究的协调研究者;HTN-J、Spyral OFF MED、Spyral ON MED、DUO、REQUIRE 和 TCD-16164 研究的站点主要研究者)。用于射频肾去神经术的肾动脉评估。A 在主肾动脉或相当于主肾动脉的中间有一条直径>3mm 的肾动脉分支时,该分支是主肾动脉的远端。在这种情况下,可以在相当于主肾动脉的部位进行四个同时进行的象限消融。B 在主肾动脉的中间有一条直径>3mm 的肾动脉分支时,该分支是主肾动脉的远端。在这种情况下,可以在相当于主肾动脉的部位进行四个同时进行的象限消融。C 在分支肾动脉中可以进行四个同时进行的象限消融。D 超声探头应至少间隔 5mm(一个探头*)放置。在动脉分叉前 2-3mm 处进行操作。在腹主动脉入口后 2-3mm 处进行操作。